Can a precise radiation boost beat prostate cancer relapse?
NCT ID NCT07343349
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial is testing two improvements to standard radiation therapy for men with high-risk prostate cancer. First, it adds a higher radiation dose (a boost) directly to the visible tumor inside the prostate, aiming to reduce the chance of cancer spreading. Second, it compares giving the radiation in 12 sessions versus 20 sessions to see if fewer treatments are just as safe and effective. About 1,000 men will take part, and the main goal is to see if the boost helps prevent distant metastases.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
radiation therapy (focal boost and hypofractionation)
What this could lead to
If successful, this could mean better control of high-risk prostate cancer with fewer hospital visits, reducing the chance of cancer spread and the need for hormone therapy.
What could go wrong
This is a large but still ongoing trial, so results are not yet known. The boost might increase side effects, and the shorter treatment schedule might not be as effective as the standard one.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aurhus University Hospital
NOT_YET_RECRUITINGAarhus, 8200, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Rigshospitalet
RECRUITINGCopenhagen, 2100, Denmark
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sygehus Lillebaelt
NOT_YET_RECRUITINGVejle, 7000, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••